CVS Group’s (CVSG) “Hold” Rating Reiterated at Jefferies Financial Group

Posted by George Bondi on Sep 28th, 2026

Jefferies Financial Group reaffirmed their hold rating on shares of CVS Group (LON:CVSG – Free Report) in a research report report published on Friday,Digital Look reports. Jefferies Financial Group currently has a GBX 1,400 price objective on the stock.

A number of other research analysts also recently weighed in on the company. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a GBX 1,700 price target on shares of CVS Group in a research note on Monday, July 27th. Shore Capital Group reiterated a “hold” rating and issued a GBX 1,400 price objective on shares of CVS Group in a report on Thursday. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 2,000 target price on shares of CVS Group in a research note on Thursday. Four equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of GBX 1,666.67.

View Our Latest Stock Analysis on CVS Group

CVS Group Stock Down 1.1%

Shares of CVS Group stock opened at GBX 1,208 on Friday. CVS Group has a 1 year low of GBX 1,062 and a 1 year high of GBX 1,648. The stock has a 50-day moving average price of GBX 1,287.09 and a 200 day moving average price of GBX 1,229.26. The company has a current ratio of 1.18, a quick ratio of 0.90 and a debt-to-equity ratio of 110.41. The company has a market cap of £821.08 million, a P/E ratio of 17.53, a P/E/G ratio of 1.77 and a beta of 1.07.

CVS Group (LON:CVSG – Get Free Report) last announced its quarterly earnings data on Thursday, September 24th. The company reported GBX 85.60 earnings per share for the quarter. CVS Group had a net margin of 2.43% and a return on equity of 5.91%. As a group, analysts expect that CVS Group will post 93.9393939 EPS for the current fiscal year.

Insider Activity

In other news, insider Joanne Shaw purchased 1,592 shares of the firm’s stock in a transaction dated Monday, August 10th. The stock was bought at an average price of GBX 1,287 per share, with a total value of £20,489.04. Also, insider David Wilton acquired 1,500 shares of the stock in a transaction that occurred on Tuesday, August 4th. The stock was purchased at an average price of GBX 1,276 per share, with a total value of £19,140. Insiders bought 3,860 shares of company stock valued at $4,956,696 in the last quarter. Company insiders own 1.48% of the company’s stock.

CVS Group News Roundup

Here are the key news stories impacting CVS Group this week:

Positive Sentiment: Dividend supported by shareholder returns: CVS Group recommended a final dividend for the year ended June 30, 2026, payable on December 4, providing an income component for investors. CVS Group recommends final dividend
Positive Sentiment: Insider purchase offers a modest confidence signal: Non-executive director Laura Hagan bought 4,128 CVS Group shares. The transaction may reassure investors about management’s view of the company’s valuation, although its financial impact is limited. CVS Group director share purchase
Positive Sentiment: Berenberg maintained a Buy rating and a GBX 2,000 price target, implying substantial upside from the stock’s recent trading level. Berenberg rating update
Neutral Sentiment: Full-year results were released: CVS Group reported GBX 85.60 in earnings per share, alongside a 2.31% net margin and 5.35% return on equity. The figures provide a fresh performance update, but the relatively low profitability metrics may limit enthusiasm without further detail on growth and costs. CVS Group full-year earnings results
Negative Sentiment: Analyst caution remains the main pressure: Shore Capital reaffirmed its Hold rating and GBX 1,400 target, while Jefferies also maintained Hold with the same target. The repeated neutral recommendations suggest limited near-term conviction despite the higher Berenberg target. Shore Capital Hold rating

CVS Group Company Profile

(Get Free Report)

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.